STAAR Surgical Co (STAA) stock
STAANasdaqOphthalmic GoodsFiscal year ends January 2
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3067% above fair value
$25.56−0.45 (-1.73%)
Close on Nov 17, 2026Market cap $1.28BP/E 365.1Yield –
STAAR Surgical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
STAAR Surgical's operating income for the twelve months ending Jul 3, 2026 was $13.73M. For fiscal 2025 it was -$91.71M. The highest annual figure on record is $43.80M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 2, 2026 | -$91.71M | – |
| FY2024 | Dec 27, 2024 | -$12.61M | -144.9% |
| FY2023 | Dec 29, 2023 | $28.10M | -35.9% |
| FY2022 | Dec 30, 2022 | $43.80M | +31.4% |
| FY2021 | Dec 31, 2021 | $33.34M | +392.5% |
| FY2020 | Jan 1, 2021 | $6.77M | -42.9% |
| FY2019 | Jan 3, 2020 | $11.85M | +79.7% |
| FY2018 | Dec 28, 2018 | $6.60M | – |
| FY2017 | Dec 29, 2017 | -$3.63M | – |
| FY2016 | Dec 30, 2016 | -$12.66M | – |
| FY2015 | Jan 1, 2016 | -$5.34M | – |
| FY2014 | Jan 2, 2015 | -$8.03M | -1246.7% |
| FY2013 | Jan 3, 2014 | $700.00K | – |
| FY2012 | Dec 28, 2012 | -$1.22M | -143.8% |
| FY2011 | Dec 30, 2011 | $2.78M | – |
| FY2010 | Dec 31, 2010 | -$2.60M | – |
| FY2009 | Jan 1, 2010 | -$4.88M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $10.10M | – |
| Q1 FY2026 | Apr 3, 2026 | $7.98M | – |
| Q4 FY2025 | Jan 2, 2026 | -$22.84M | – |
| Q3 FY2025 | Sep 26, 2025 | $18.49M | +225.4% |
| Q2 FY2025 | Jun 27, 2025 | -$29.96M | -351.8% |
| Q1 FY2025 | Mar 28, 2025 | -$57.40M | – |
| Q4 FY2024 | Dec 27, 2024 | -$27.91M | -368.2% |
| Q3 FY2024 | Sep 27, 2024 | $5.68M | -9.7% |
| Q2 FY2024 | Jun 28, 2024 | $11.90M | +38.4% |
| Q1 FY2024 | Mar 29, 2024 | -$2.28M | -181.5% |
| Q4 FY2023 | Dec 29, 2023 | $10.41M | +979.4% |
| Q3 FY2023 | Sep 29, 2023 | $6.30M | -54.1% |
| Q2 FY2023 | Jun 30, 2023 | $8.60M | -49.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.80M | -76.9% |
| Q4 FY2022 | Dec 30, 2022 | $964.00K | -86.9% |
| Q3 FY2022 | Sep 30, 2022 | $13.71M | +74.9% |
| Q2 FY2022 | Jul 1, 2022 | $17.02M | +59.8% |
| Q1 FY2022 | Apr 1, 2022 | $12.11M | +62.2% |
| Q4 FY2021 | Dec 31, 2021 | $7.38M | +81.1% |
| Q3 FY2021 | Oct 1, 2021 | $7.84M | +60.5% |
| Q2 FY2021 | Jul 2, 2021 | $10.65M | – |
| Q1 FY2021 | Apr 2, 2021 | $7.47M | – |
| Q4 FY2020 | Jan 1, 2021 | $4.08M | +74.1% |
| Q3 FY2020 | Oct 2, 2020 | $4.88M | +46.4% |
| Q2 FY2020 | Jul 3, 2020 | -$1.06M | -122.9% |
| Q1 FY2020 | Apr 3, 2020 | -$1.14M | -172.5% |
| Q4 FY2019 | Jan 3, 2020 | $2.34M | +97.3% |
| Q3 FY2019 | Sep 27, 2019 | $3.33M | +110.6% |
| Q2 FY2019 | Jun 28, 2019 | $4.61M | +52.4% |
| Q1 FY2019 | Mar 29, 2019 | $1.57M | +95.9% |
| Q4 FY2018 | Dec 28, 2018 | $1.19M | – |
| Q3 FY2018 | Sep 28, 2018 | $1.58M | +51.6% |
| Q2 FY2018 | Jun 29, 2018 | $3.03M | – |
| Q1 FY2018 | Mar 30, 2018 | $799.00K | – |
| Q4 FY2017 | Dec 29, 2017 | -$1.26M | -200.3% |
| Q3 FY2017 | Sep 29, 2017 | $1.04M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.32M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.08M | – |
| Q4 FY2016 | Dec 30, 2016 | $1.26M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.72M | – |
See a number that looks wrong?